HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

tetramethylreductic acid (TMRA)

structure given in first source

Also Known As:

TMRA; 4,4,5,5-tetramethyl-2,3-dihydroxy-2-cyclopenten-1-one

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Carboxylic Acids: 973
  - Hydroxy Acids: 94
    - Sugar Acids: 4
      - Ascorbic Acid: 10913
        tetramethylreductic acid: 1
  - Acyclic Acids
    - Sugar Acids: 4
      - Ascorbic Acid: 10913
        tetramethylreductic acid: 1
Carbohydrates: 22023
- Sugar Acids: 4
  - Ascorbic Acid: 10913
    - tetramethylreductic acid: 1

Experts

1.	Amarsanaa, Gereltuya: 1 article (01/2022)
2.	Choimaa, Lodoiravsal: 1 article (01/2022)
3.	Hashimoto, Kenichi: 1 article (01/2022)
4.	Matsui, Takemi: 1 article (01/2022)
5.	Purevsuren, Otgonbat: 1 article (01/2022)
6.	Sun, Guanghao: 1 article (01/2022)
7.	Unursaikhan, Batbayar: 1 article (01/2022)

Related Diseases

1.	Infections 01/01/2022 - "Conclusion: Under clinical settings with body motion, the VISC-Camera with TMRA appears promising for the preliminary screening of potential COVID-19 infection for afebrile patients with the possibility of misdiagnosis as asymptomatic." 01/01/2022 - "Background: To conduct a rapid preliminary COVID-19 screening prior to polymerase chain reaction (PCR) test under clinical settings, including patient's body moving conditions in a non-contact manner, we developed a mobile and vital-signs-based infection screening composite-type camera (VISC-Camera) with truncus motion removal algorithm (TMRA) to screen for possibly infected patients. "
2.	COVID-19 01/01/2022 - "Conclusion: Under clinical settings with body motion, the VISC-Camera with TMRA appears promising for the preliminary screening of potential COVID-19 infection for afebrile patients with the possibility of misdiagnosis as asymptomatic." 01/01/2022 - "Background: To conduct a rapid preliminary COVID-19 screening prior to polymerase chain reaction (PCR) test under clinical settings, including patient's body moving conditions in a non-contact manner, we developed a mobile and vital-signs-based infection screening composite-type camera (VISC-Camera) with truncus motion removal algorithm (TMRA) to screen for possibly infected patients. "